Pediatric Cysticercosis Differential Diagnoses

1. Schantz PM, Moore AC, Munoz JL, et al. Neurocysticercosis in an Orthodox Jewish community in New York City. N Engl J Med. 1992 Sep 3. 327(10):692-5. [Medline].

2. O'Neal SE, Flecker RH. Hospitalization frequency and charges for neurocysticercosis, United States, 2003-2012. Emerg Infect Dis. 2015 Jun. 21 (6):969-76. [Medline].

3. Garcia HH, Gonzalez AE, Tsang VC, O'Neal SE, Llanos-Zavalaga F, Gonzalvez G, et al. Elimination of Taenia solium Transmission in Northern Peru. N Engl J Med. 2016 Jun 16. 374 (24):2335-44. [Medline].

4. Raffaldi I, Scolfaro C, Mignone F, Aguzzi S, Denegri F, Tovo PA. An uncommon cause of seizures in children living in developed countries: neurocysticercosis--a case report. Ital J Pediatr. 2011 Jan 25. 37:9. [Medline]. [Full Text].

5. Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol. 2014 Dec. 13 (12):1202-15. [Medline].

6. Murthy R, Samant M. Extraocular muscle cysticercosis: clinical features and management outcome. Strabismus. 2008 Jul-Sep. 16(3):97-106. [Medline].

7. Zammarchi L, Angheben A, Gobbi F, Zavarise G, Requena-Mendez A, Marchese V, et al. Profile of adult and pediatric neurocysticercosis cases observed in five Southern European centers. Neurol Sci. 2016 Aug. 37 (8):1349-55. [Medline].

8. Krumholz A, Wiebe S, Gronseth G, et al. Practice Parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2007 Nov 20. 69(21):1996-2007. [Medline].

9. Quintana LM. Cysticercosis treatment- A complex interaction drug-parasite-host. World Neurosurg. 2012 Feb 22. [Medline].

10. AAP Committee on Infectious Diseases. Cysticercosis. AAP 2000 Red Book: Report of the Committee on Infectious Diseases. 25th ed. 2000. 560-2.

11. Abuseir S, Kuhne M, Schnieder T, Klein G, Epe C. Evaluation of a serological method for the detection of Taenia saginata cysticercosis using serum and meat juice samples. Parasitol Res. 2007 Jun. 101(1):131-7. [Medline].

12. Ahmad FU, Sharma BS. Treatment of intramedullary spinal cysticercosis: report of 2 cases and review of literature. Surg Neurol. 2007 Jan. 67(1):74-7; discussion 77. [Medline].

13. Alonso-Trujillo J, Rivera-Montoya I, Rodriguez-Sosa M, Terrazas LI. Nitric oxide contributes to host resistance against experimental Taenia crassiceps cysticercosis. Parasitol Res. 2007 Jan 6. [Medline].

14. Bhigjee AI, Rosemberg S. Optimizing therapy of seizures in patients with HIV and cysticercosis. Neurology. 2006 Dec 26. 67(12 Suppl 4):S19-22. [Medline].

15. Blanton R. Cysticercosis. Nelson Textbook of Pediatrics. 16th ed. Philadelphia, PA: WB Saunders; 2000. 1078-9.

16. Cohn-Zurita F, Guinto-Balanzar G, Perez-Cerdan H. [Neurocysticercosis associated with pituitary adenoma. Case report and literature review.]. Cir Cir. 2006 Jan-Feb. 74(1):47-9. [Medline].

17. Evans CAW, Garcia HH, Gilman RH. Cysticercosis. Hunter's Tropical Medicine and Emerging Infectious Diseases. Philadelphia, PA: WB Saunders; 2000. 862-6.

18. Facanha MC. [Cysticercosis' admissions in public health hospitals: Ceara State distribuition]. Rev Soc Bras Med Trop. 2006 Sep-Oct. 39(5):484-7. [Medline].

19. Galan-Puchades MT, Fuentes MV. The specificity of the electroimmunotransfer blot assay for Taenia solium cysticercosis. Clin Microbiol Infect. 2007 Jan. 13(1):111-2; author reply 112. [Medline].

20. Garcia HH, Cancrini G, Bartalesi F, et al. Evaluation of immunodiagnostics for toxocarosis in experimental porcine cysticercosis. Trop Med Int Health. 2007 Jan. 12(1):107-10. [Medline].

21. Garcia HH, Del Brutto OH. Taenia solium cysticercosis. Infect Dis Clin North Am. 2000 Mar. 14(1):97-119, ix. [Medline].

22. Geysen D, Kanobana K, Victor B, et al. Validation of meat inspection results for Taenia saginata cysticercosis by PCR-restriction fragment length polymorphism. J Food Prot. 2007 Jan. 70(1):236-40. [Medline].

23. Goetz CG, Pappert EJ. Textbook of Clinical Neurology. Philadelphia, PA: WB Saunders; 1999.

24. Ishida MM, Peralta RH, Livramento JA, et al. Serodiagnosis of neurocysticercosis in patients with epileptic seizure using ELISA and immunoblot assay. Rev Inst Med Trop Sao Paulo. 2006 Nov-Dec. 48(6):343-6. [Medline].

25. King CH. Cestode infections. Cecil Textbook of Medicine. 21st ed. 2000. 1975-8.

26. King CH. Cestodes (tapeworms). Mandell's Principles and Practice of Infectious Diseases. 5th ed. New York, NY: Churchill Livingstone; 2000. 2956-62.

27. Kumar A, Pushker N, Bajaj MS, et al. Unifocal, subconjunctival twin cysticercosis cysts. J Pediatr Ophthalmol Strabismus. 2007 Jan-Feb. 44(1):55-6. [Medline].

28. Li T, Craig PS, Ito A, et al. Taeniasis/cysticercosis in a Tibetan population in Sichuan Province, China. Acta Trop. 2006 Dec. 100(3):223-231. [Medline].

29. Mahajan D, Khurana N, Setia N. Coexistence of salivary gland cysticercosis with squamous cell carcinoma of the mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jan 11. [Medline].

30. Manfredi MT, Ghirardelli R, Zanzani S. [Cysticercus tenuicollis infection in a goat farm]. Parassitologia. 2006 Sep. 48(3):433-6. [Medline].

31. Proano JV, Madrazo I, Avelar F, et al. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med. 2001. 345(12):879-85. [Medline]. [Full Text].

32. Rajshekhar V, Raghava MV, Prabhakaran V, et al. Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India. Neurology. 2006 Dec 26. 67(12):2135-9. [Medline].

33. Rodriguez-Hidalgo R, Benitez-Ortiz W, Praet N, et al. Taeniasis-cysticercosis in Southern Ecuador: assessment of infection status using multiple laboratory diagnostic tools. Mem Inst Oswaldo Cruz. 2006 Nov. 101(7):779-82. [Medline].

34. Sandes AR, Mouzinho A, Valente P. Orbital cysticercosis: diagnosis and treatment controversies. Pediatr Infect Dis J. 2007 Feb. 26(2):180-1. [Medline].

35. Sciutto E, Rosas G, Hernandez M, et al. Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccine. Vaccine. 2007 Feb 9. 25(8):1368-78. [Medline].

36. Singhi P, Dayal D, Khandelwal N. One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial. Pediatr Infect Dis J. 2003. 22(3):268-72. [Medline].

37. Singhi P, Singhi S. Neurocysticercosis in children. Indian J Pediatr. 2009 May. 76(5):537-45. [Medline].

38. Verulashvili I, Glonti L, Miminoshvili D, et al. [Basal Ganglia calcification: clinical manifestations and diagnostic evaluation.]. Georgian Med News. 2006 Nov. 39-43. [Medline].

39. Zheng Y, Cai X, Luo X, et al. Characterization of a new gene (SLC10) with a spliced leader from Taenia solium. Vet J. 2007 Feb 2. [Medline].

40. Sharma M, Singh T, Mathew A. Antiepileptic drugs for seizure control in people with neurocysticercosis. Cochrane Database Syst Rev. 2015 Oct 12. CD009027. [Medline].

Delaram Ghadishah, MD Physician, Emergency Department, Kaiser Permanente West Los Angeles Medical Center

Delaram Ghadishah, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians

Disclosure: Nothing to disclose.

Michael James Burns, MD, FACEP, FACP, FIDSA Health Science Clinical Professor, Department of Emergency Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of California Irvine School of Medicine

Michael James Burns, MD, FACEP, FACP, FIDSA is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians, American College of Physicians, American Geriatrics Society, American Society of Tropical Medicine and Hygiene, California Medical Association, Infectious Diseases Society of America, Phi Beta Kappa, Royal Society of Tropical Medicine and Hygiene, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Martin Weisse, MD Program Director, Associate Professor, Department of Pediatrics, West Virginia University

Martin Weisse, MD is a member of the following medical societies: Academic Pediatric Association, American Academy of Pediatrics, Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Russell W Steele, MD Clinical Professor, Tulane University School of Medicine; Staff Physician, Ochsner Clinic Foundation

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, Southern Medical Association

Disclosure: Nothing to disclose.

Glenn Fennelly, MD, MPH Director, Division of Infectious Diseases, Lewis M Fraad Department of Pediatrics, Jacobi Medical Center; Clinical Associate Professor of Pediatrics, Albert Einstein College of Medicine

Glenn Fennelly, MD, MPH is a member of the following medical societies: Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article